ISRG, EW and ELMD tap GenAI to enhance diagnostics and workflows, even as MedTech faces cost pressures, data risks and macro headwinds.
3 Medical Instrument Stocks Banking on GenAI to Tackle Industry Woes
Related Posts
New Strong Sell Stocks for February 11th
DDL, IAC and LCID have been added to the Zacks Rank #5 (Strong Sell) List on February 11, 2026.
Warren Buffett Hits the Sell Button on Multiple Core Holdings for $15.5 Billion — Time to Panic?
Berkshire Hathaway is selling several major positions.
Fund Rotates Into Insurance Stock With Big Purchase
Wealthedge acquired more than $3.3 million worth of RLI stock during the third quarter.